{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:33:44Z","timestamp":1765280024910},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.yexcr.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T18:06:13Z","timestamp":1518631573000},"page":"30-36","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["PAX5 haploinsufficiency induce cancer cell dormancy in Raji cells"],"prefix":"10.1016","volume":"367","author":[{"given":"Xue","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TongJuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2018.02.010_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-385991-4.00005-2","article-title":"Pax5: a master regulator of B cell development and leukemogenesis","volume":"111","author":"Medvedovic","year":"2011","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.yexcr.2018.02.010_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genomewide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2018.02.010_bib3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3324\/haematol.2009.020792","article-title":"The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. a report on behalf of theGIMEMAacute leukemiaworkingparty","volume":"95","author":"Iacobucci","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2018.02.010_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcmd.2011.04.003","article-title":"PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia","volume":"47","author":"Kim","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.yexcr.2018.02.010_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2005-10-3949","article-title":"Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte- predominant and classicHodgkin lymphoma","volume":"108","author":"Liso","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2018.02.010_bib6","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood-2002-11-3606","article-title":"Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma","volume":"102","author":"Gaidano","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2018.02.010_bib7","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood-2003-05-1465","article-title":"Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation","volume":"103","author":"Montesinos-Rongen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2018.02.010_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/leu.2015.140","article-title":"Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1","volume":"30","author":"Teo","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2018.02.010_bib9","first-page":"287","article-title":"Significance of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia without reproducible chromosomal abnormalities","volume":"18","author":"Liu","year":"2016","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"23","key":"10.1016\/j.yexcr.2018.02.010_bib10","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1182\/blood-2015-02-626127","article-title":"PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia","volume":"125","author":"Dang","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.yexcr.2018.02.010_bib11","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/onc.2011.291","article-title":"Dominant-negative mechanism of leukemogenic PAX5 fusions","volume":"31","author":"Kawamata","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2018.02.010_bib12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20101947","article-title":"Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acutelymphoblastic leukemia","volume":"208","author":"Heltemes-Harris","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2018.02.010_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.V112.11.293.293","article-title":"Pax5 haploinsufficiency cooperates with BCR-ABL1 to induce acute lymphoblastic leukemia","volume":"112","author":"Christopher","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2018.02.010_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature06159","article-title":"Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors","volume":"449","author":"Cobaleda","year":"2007","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.yexcr.2018.02.010_bib15","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1158\/0008-5472.CAN-15-1370","article-title":"Mechanisms of cancer cell dormancy--Another hallmark of cancer?","volume":"75","author":"Yeh","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2018.02.010_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2018.02.010_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrc2256","article-title":"Models, mechanisms and clinical evidence for cancer dormancy","volume":"7","author":"Aguirre-Ghiso","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.yexcr.2018.02.010_bib18","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/0008-5472.CAN-13-3437","article-title":"Cancer cell dormancy in novel mouse models for reversible pancreatic cancer: a lingering challenge in the development of targeted therapies","volume":"74","author":"Lin","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2018.02.010_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nbt.2842","article-title":"CRISPR-Cas systems for editing, regulating and targeting genomes","volume":"32","author":"Sander","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2018.02.010_bib20","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1182\/blood-2006-05-025221","article-title":"A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5","volume":"109","author":"Bousquet","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2018.02.010_bib21","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/leu.2009.135","article-title":"PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study","volume":"23","author":"Familiades","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2018.02.010_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5326370","article-title":"Identification of significant pathways induced by PAX5 Haploinsufficiency based on protein-protein interaction networks and cluster analysis in Raji cell line","author":"Gu","year":"2017","journal-title":"BioMed. Res. Int."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718300843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718300843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T04:47:38Z","timestamp":1603860458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482718300843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0014482718300843"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.010","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAX5 haploinsufficiency induce cancer cell dormancy in Raji cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}